Objective: To compare the flavour and taste preferences of two acid-inhibitory therapies in children. Subjects and Setting: 104 (52 male and 52 female) healthy children aged 6-11 years participated in ...

The US Food and Drug Administration (FDA) on Thursday issued new draft guidance covering the quality attributes drugmakers should consider when developing chewable tablets. The guidance also includes ...

Clinical trial data demonstrate that Cavhanza can be taken with or without food, offering patients greater administration convenience.

Charles Ischi produces the DISI-A Touch, an automatic disintegration tester that allows the user to control all operation and data analysis using a computer and PH21 software. The system fulfils the ...

Drug delivery as solid dosage forms is complex with a number of factors that can noticeably influence their therapeutic benefit. The drug must be stabilized in the tablet and at the same time be ...

AZoMaterials speaks to Dr. Simon Bates and Dr. Angela Criswell about how X-ray CT imaging is transforming tablet design and quality control, revealing how microstructure drives dissolution, ...

The study was conducted at a contract research organisation site (Hilltop Research, Inc., Scottsdale, AZ, USA). Healthy children from 6 to 11 years of age, with a minimum bodyweight of 16.8kg (37lbs), ...